• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

与丙氨酸转氨酶相关的早幼粒细胞白血病小体存在于活细胞中,且在细胞周期的G(2)/M期细胞中富集。

ALT-associated PML bodies are present in viable cells and are enriched in cells in the G(2)/M phase of the cell cycle.

作者信息

Grobelny J V, Godwin A K, Broccoli D

机构信息

Fox Chase Cancer Center, Philadelphia PA 1911, USA.

出版信息

J Cell Sci. 2000 Dec;113 Pt 24:4577-85. doi: 10.1242/jcs.113.24.4577.

DOI:10.1242/jcs.113.24.4577
PMID:11082050
Abstract

Telomere maintenance is essential for the unlimited proliferative potential of human cells, and hence immortalization. However, a number of tumors, tumor-derived cell lines and in vitro immortalized cell lines have been described that do not express detectable telomerase activity. These lines utilize a mechanism, termed Alternative Lengthening of Telomeres (ALT), to provide telomere maintenance. A subset of the cells in each ALT cell line contain a novel form of the promyelocytic leukemia nuclear body (PML NB) in which telomeric DNA and the telomere binding proteins TRF1 and TRF2 co-localize with the PML protein, termed ALT-associated PML bodies (AA-PBs). In contrast, in non-ALT, telomerase-positive cell lines these telomeric proteins and the PML NB occupy distinct and separate subnuclear domains. PML NBs have been implicated in terminal differentiation, growth suppression and apoptosis. The role, if any, of AA-PBs in telomere maintenance or culture viability in telomerase negative cell lines is unclear, but it has been suggested that cells containing these structures are no longer viable and are marked for eventual death. We utilized a series of human ovarian surface epithelium (HOSE) cell lines that use ALT for telomere maintenance to determine if AA-PBs are indeed markers of cells in these cultures that are no longer cycling. We show that AA-PB positive cells incorporate BrdU and thus are able to carry out DNA replication. In addition, AA-PBs are present in mitotic cells and the frequency of cells containing these structures is increased when cultures are enriched for cells in the G(2)/M phase of the cell cycle suggesting that the formation of AA-PBs is coordinately regulated with the cell cycle. Finally, we demonstrate that the majority of the AA-PB positive cells in the culture are not destined for immediate apoptosis. Taken together the data argue against AA-PBs marking cells destined for death and, instead, raise the possibility that these structures may be actively involved in telomere maintenance via the ALT pathway.

摘要

端粒维持对于人类细胞无限增殖潜能以及永生至关重要。然而,已描述了许多不表达可检测到的端粒酶活性的肿瘤、肿瘤衍生细胞系和体外永生化细胞系。这些细胞系利用一种称为端粒替代延长(ALT)的机制来维持端粒。每个ALT细胞系中的一部分细胞含有一种新型的早幼粒细胞白血病核体(PML NB),其中端粒DNA以及端粒结合蛋白TRF1和TRF2与PML蛋白共定位,称为ALT相关PML小体(AA-PBs)。相比之下,在非ALT、端粒酶阳性细胞系中,这些端粒蛋白和PML NB占据不同且分开的核内亚结构域。PML NB与终末分化、生长抑制和细胞凋亡有关。AA-PBs在端粒维持或端粒酶阴性细胞系的培养生存力中的作用(如果有)尚不清楚,但有人提出含有这些结构的细胞不再具有活力,并注定最终死亡。我们利用一系列使用ALT维持端粒的人卵巢表面上皮(HOSE)细胞系来确定AA-PBs是否确实是这些培养物中不再循环的细胞的标志物。我们发现AA-PB阳性细胞掺入BrdU,因此能够进行DNA复制。此外,有丝分裂细胞中存在AA-PBs,当培养物富集处于细胞周期G(2)/M期的细胞时,含有这些结构的细胞频率增加,这表明AA-PBs的形成与细胞周期协同调节。最后,我们证明培养物中大多数AA-PB阳性细胞并非注定立即凋亡。综上所述,这些数据反对AA-PBs标记注定死亡的细胞,相反,增加了这些结构可能通过ALT途径积极参与端粒维持的可能性。

相似文献

1
ALT-associated PML bodies are present in viable cells and are enriched in cells in the G(2)/M phase of the cell cycle.与丙氨酸转氨酶相关的早幼粒细胞白血病小体存在于活细胞中,且在细胞周期的G(2)/M期细胞中富集。
J Cell Sci. 2000 Dec;113 Pt 24:4577-85. doi: 10.1242/jcs.113.24.4577.
2
Effects of reconstitution of telomerase activity on telomere maintenance by the alternative lengthening of telomeres (ALT) pathway.端粒酶活性重建对通过端粒替代延长(ALT)途径进行端粒维持的影响。
Hum Mol Genet. 2001 Sep 1;10(18):1953-61. doi: 10.1093/hmg/10.18.1953.
3
PML and TRF2 protein expression in hereditary and sporadic colon cancer.PML和TRF2蛋白在遗传性和散发性结肠癌中的表达
Neoplasma. 2007;54(4):269-77.
4
Identification of candidate alternative lengthening of telomeres genes by methionine restriction and RNA interference.通过甲硫氨酸限制和RNA干扰鉴定端粒候选替代延长基因
Oncogene. 2007 Jul 12;26(32):4635-47. doi: 10.1038/sj.onc.1210260. Epub 2007 Feb 5.
5
Disruption of BRCA1 function results in telomere lengthening and increased anaphase bridge formation in immortalized cell lines.BRCA1功能的破坏导致永生化细胞系中的端粒延长和后期桥形成增加。
Genes Chromosomes Cancer. 2006 Mar;45(3):277-89. doi: 10.1002/gcc.20290.
6
Lack of TRF2 in ALT cells causes PML-dependent p53 activation and loss of telomeric DNA.端粒酶替代延长(ALT)细胞中缺乏TRF2会导致依赖PML的p53激活和端粒DNA丢失。
J Cell Biol. 2007 Dec 3;179(5):855-67. doi: 10.1083/jcb.200703020.
7
PML3 interacts with TRF1 and is essential for ALT-associated PML bodies assembly in U2OS cells.PML3 与 TRF1 相互作用,是 U2OS 细胞中 ALT 相关 PML 体组装所必需的。
Cancer Lett. 2010 May 28;291(2):177-86. doi: 10.1016/j.canlet.2009.10.009. Epub 2009 Nov 8.
8
Telomerase-negative immortalized human cells contain a novel type of promyelocytic leukemia (PML) body.端粒酶阴性的永生化人类细胞含有一种新型的早幼粒细胞白血病(PML)小体。
Cancer Res. 1999 Sep 1;59(17):4175-9.
9
Probing PML body function in ALT cells reveals spatiotemporal requirements for telomere recombination.探究PML小体在ALT细胞中的功能揭示了端粒重组的时空需求。
Proc Natl Acad Sci U S A. 2009 Sep 15;106(37):15726-31. doi: 10.1073/pnas.0907689106. Epub 2009 Aug 26.
10
De novo assembly of a PML nuclear subcompartment occurs through multiple pathways and induces telomere elongation.通过多种途径进行 PML 核亚区的从头组装,并诱导端粒延长。
J Cell Sci. 2011 Nov 1;124(Pt 21):3603-18. doi: 10.1242/jcs.084681.

引用本文的文献

1
A parent-of-origin effect on embryonic telomere elongation determines telomere length inheritance.亲本来源对胚胎端粒延长的影响决定了端粒长度的遗传。
bioRxiv. 2025 Jan 29:2025.01.28.635226. doi: 10.1101/2025.01.28.635226.
2
Cancer-associated DAXX mutations reveal a critical role for ATRX localization in ALT suppression.癌症相关的DAXX突变揭示了ATRX定位在端粒延长替代途径(ALT)抑制中的关键作用。
bioRxiv. 2024 Nov 20:2024.11.18.624165. doi: 10.1101/2024.11.18.624165.
3
Tracking Small Extracellular Vesicles Using a Minimally Invasive PicoGreen Labeling Strategy.
使用微创 PicoGreen 标记策略追踪小型细胞外囊泡。
ACS Appl Bio Mater. 2024 Nov 18;7(11):7770-7783. doi: 10.1021/acsabm.4c01500. Epub 2024 Oct 31.
4
Polyubiquitinated PCNA triggers SLX4-mediated break-induced replication in alternative lengthening of telomeres (ALT) cancer cells.多聚泛素化 PCNA 触发 SLX4 介导的断裂诱导复制,在端粒延长(ALT)癌症细胞中。
Nucleic Acids Res. 2024 Oct 28;52(19):11785-11805. doi: 10.1093/nar/gkae785.
5
Prevalence of alternative lengthening of telomeres in pediatric sarcomas determined by the telomeric DNA C-circle assay.通过端粒DNA C环分析确定的小儿肉瘤中端粒替代延长的发生率。
Front Oncol. 2024 Aug 19;14:1399442. doi: 10.3389/fonc.2024.1399442. eCollection 2024.
6
Distinct modes of telomere synthesis and extension contribute to Alternative Lengthening of Telomeres.端粒合成和延长的不同模式促成了端粒的替代延长。
iScience. 2023 Dec 11;27(1):108655. doi: 10.1016/j.isci.2023.108655. eCollection 2024 Jan 19.
7
Alternative lengthening of telomeres (ALT) cells viability is dependent on C-rich telomeric RNAs.端粒的替代性延长(ALT)细胞的存活依赖于富含 C 的端粒 RNA。
Nat Commun. 2023 Nov 4;14(1):7086. doi: 10.1038/s41467-023-42831-0.
8
Telomeric DNA breaks in human induced pluripotent stem cells trigger ATR-mediated arrest and telomerase-independent telomere damage repair.人诱导多能干细胞中端粒 DNA 断裂引发 ATR 介导的阻滞和端粒酶非依赖性端粒损伤修复。
J Mol Cell Biol. 2024 Aug 26;16(3). doi: 10.1093/jmcb/mjad058.
9
Genome maintenance meets mechanobiology.基因组维护与机械生物学相遇。
Chromosoma. 2024 Jan;133(1):15-36. doi: 10.1007/s00412-023-00807-5. Epub 2023 Aug 15.
10
Potential clinical treatment prospects behind the molecular mechanism of alternative lengthening of telomeres (ALT).端粒替代延长(ALT)分子机制背后的潜在临床治疗前景。
J Cancer. 2023 Jan 31;14(3):417-433. doi: 10.7150/jca.80097. eCollection 2023.